GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 125 filers reported holding GOSSAMER BIO INC in Q4 2020. The put-call ratio across all filers is 0.46 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $14,098,000 | -23.1% | 1,457,886 | -1.3% | 0.01% | -33.3% |
Q3 2020 | $18,325,000 | -4.2% | 1,476,643 | +0.4% | 0.02% | -11.8% |
Q2 2020 | $19,127,000 | +165.6% | 1,471,308 | +107.4% | 0.02% | +88.9% |
Q1 2020 | $7,201,000 | -23.9% | 709,433 | +17.2% | 0.01% | -10.0% |
Q4 2019 | $9,461,000 | -6.9% | 605,299 | 0.0% | 0.01% | -9.1% |
Q3 2019 | $10,163,000 | -30.5% | 605,299 | -8.2% | 0.01% | -26.7% |
Q2 2019 | $14,630,000 | +2.1% | 659,609 | -0.2% | 0.02% | +7.1% |
Q1 2019 | $14,326,000 | – | 661,116 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |